The US-China summit is “extremely important” to arrest the downward spiral of relations between the two countries, according to Li Cheng, a leading Chinese academic. But a summit would not be enough to change the overall structure of ties, which had been fraught for years, Li said on Thursday as US President Donald Trump began the first full day of his state visit to Beijing – the first by an Amer...
The US-China summit is “extremely important” to arrest the downward spiral of relations between the two countries, according to Li Cheng, a leading Chinese academic. But a summit would not be enough to change the overall structure of ties, which had been fraught for years, Li said on Thursday as US President Donald Trump began the first full day of his state visit to Beijing – the first by an American leader since 2017. The two presidents began the day with two hours of talks at the Great Hall...
Editor's note: Seeking Alpha is proud to welcome Beta Sigma Quant as a new contributing analyst. You can become one too! Share your best investment idea by submitting your article for review to our editors. Get published, earn money, and unlock exclusive SA Premium access. Click here to find out more » JonnyJim/iStock via Getty Images Thesis I believe the current valuation of EyePoint ( EYPT ) ref...
Editor's note: Seeking Alpha is proud to welcome Beta Sigma Quant as a new contributing analyst. You can become one too! Share your best investment idea by submitting your article for review to our editors. Get published, earn money, and unlock exclusive SA Premium access. Click here to find out more » JonnyJim/iStock via Getty Images Thesis I believe the current valuation of EyePoint ( EYPT ) reflects either a higher perception of clinical and regulatory risk or a more cautious view on DURAVYU's commercial potential. In my central case, the stock offers roughly 2x upside. In my view, EYPT is a clear BUY driven by a meaningful durability advantage that should translate into reduced treatment burden. My valuation reflects a probability-weighted outcome. Positive results would likely drive a significant re-rating, whereas failure would lead to a very substantial decline in EYPT value. EyePoint EyePoint is a clinical-stage biotech company developing therapeutics for retinal diseases. The company's website indicates that its " lead product candidate, DURAVYU™ (vorolanib intravitreal insert), is presently in Phase 3 clinical trials for neovascular age-related macular degeneration (wet AMD) and diabetic macular edema (DME). " Despite annual revenues of approximately $30 million in 2025, the company's market capitalization stood at approximately $1.14 billion as of May 12, 2026; the current valuation is largely driven by expectations around DURAVYU. According to management , top-line Phase 3 data in wet AMD are expected beginning mid-2026. The main value driver is the potential entry of DURAVYU into the wet AMD market, an approximately $10 billion market. Some reports indicate an expected 6% - 9% annual growth rate fuelled by increased prices in treatments and an aging population. The DME indication - an approximately $4 billion market - may provide a significant incremental value. The Wet AMD Market Wet AMD primarily affects an elderly population. Most patients are in the...
Manipal Health Enterprises Pvt. , which runs the Manipal Hospitals chain, is set to begin formal marketing as early as next week for its planned initial public offering to raise more than $1 billion, according to people familiar with the matter. The Temasek Holdings Pte. -backed company is targeting a valuation of about $12 billion during two weeks of meetings with domestic and international inves...
Manipal Health Enterprises Pvt. , which runs the Manipal Hospitals chain, is set to begin formal marketing as early as next week for its planned initial public offering to raise more than $1 billion, according to people familiar with the matter. The Temasek Holdings Pte. -backed company is targeting a valuation of about $12 billion during two weeks of meetings with domestic and international investors, the people said, asking not to be identified because the information is private. Deliberations are ongoing and details of the offering including its size and timing could still change, the people said. A representative for Manipal Hospitals didn’t immediately respond to requests for comment. Indian equity markets are gradually recovering from recent declines linked to geopolitical tensions in the Middle East, alongside government efforts to stabilize the fiscal outlook. Manipal Hospitals filed its draft prospectus with India’s market regulator in March. The proposed share sale includes a secondary offering of as many as 43.23 million shares, or about a 3.66% stake, by existing investors, as well as a fresh issue of shares worth about 80 billion rupees ($960 million), according to the filing. Selling shareholders in the secondary portion include TPG, Temasek, Ammar Sdn. Bhd., Novo Holdings Invest Asia, Phoenix Bear Investments LLC, Seventy Second Investment Company LLC and Manipal Education and Medical Group India Pvt. Ltd. For the latest news on equity capital markets activity in the Asia-Pacific region, follow the channel or visit NI BFWECMAS . To subscribe to ECM Watch , Bloomberg’s daily roundup of news from around the region, click here . The company is working with advisers including Kotak Mahindra Capital Co., Axis Bank Ltd., and the local units of Goldman Sachs Group Inc., JPMorgan Chase & Co., Jefferies Financial Group Inc., UBS Securities and DBS Bank Ltd. on the potential listing, according to the prospectus.
Teekay ( TK ) declares $1.00/share special dividend . Payable June 2; for shareholders of record May 26; ex-div May 26. See TK Dividend Scorecard, Yield Chart, & Dividend Growth. More on Teekay Teekay Corporation: Time To Rotate Into Teekay Tankers (Rating Downgrade) Teekay Corporation Ltd. (TK) Q4 2025 Earnings Call Transcript Teekay Corporation Ltd. 2025 Q4 - Results - Earnings Call Presentation...
Teekay ( TK ) declares $1.00/share special dividend . Payable June 2; for shareholders of record May 26; ex-div May 26. See TK Dividend Scorecard, Yield Chart, & Dividend Growth. More on Teekay Teekay Corporation: Time To Rotate Into Teekay Tankers (Rating Downgrade) Teekay Corporation Ltd. (TK) Q4 2025 Earnings Call Transcript Teekay Corporation Ltd. 2025 Q4 - Results - Earnings Call Presentation VLGC rates hit record highs as Hormuz shutdown reshapes global LPG trade flows Strait of Hormuz oil tanker traffic blocked after Israeli strikes, Iranian media says
Two India-bound vessels laden with cooking fuel from the Persian Gulf appear to have transited the Strait of Hormuz, making them the latest to exit despite continued restrictions from the US and Iran. One of the liquefied petroleum gas carriers, Symi , emerged in the Gulf of Oman on Thursday after turning off its transponder, with the other — NV Sunshine — went dark just after making it through th...
Two India-bound vessels laden with cooking fuel from the Persian Gulf appear to have transited the Strait of Hormuz, making them the latest to exit despite continued restrictions from the US and Iran. One of the liquefied petroleum gas carriers, Symi , emerged in the Gulf of Oman on Thursday after turning off its transponder, with the other — NV Sunshine — went dark just after making it through the strait. The two passages take the number of large ships carrying oil, fuel and gas that have made it through Hormuz since Sunday to nine. That’s an increase from recent weeks and comes despite a deadlock in negotiations to end the war. A growing number of Persian Gulf exporters are managing to get their cargoes out. Abu Dhabi National Oil Co. is among those that have been shipping fuel on vessels moving through the strait without broadcasting their locations. The NV Sunshine, which loaded LPG at the United Arab Emirates’ Ruwais refinery, last transmitted its location east of Iran’s Larak Island early on Thursday, signaling it was headed to Mangalore in India, ship-tracking data show. The Symi is transporting fuel from Qatar’s Ras Laffan to Kandla in western India. Read More: Aramco, Adnoc Sneak Oil Through Hormuz as Iran Menaces Strait The other seven vessels that have recently made it through the strait include two more with LPG, four very large crude carriers and one liquefied natural gas tanker. Some are still inside the US blockade line that runs from Rad al Hadd in Oman to the Iran-Pakistan border. The Agios Fanourios I, a Vietnam-bound supertanker laden with Iraqi crude, is currently idling in the Gulf of Oman after having been turned around by the US Navy. Sailing past it on Thursday was the Chinese tanker Yuan Hua Hu, which has crossed the American blockade line, with Japan’s Eneos Endeavor trailing behind it very near the line. Another VLGC, the Tara Gas that was known to have dabbled in the Iranian trade, also recently crossed the US line, heading in the directi...